WHO Disability Assessment Schedule 2.0 (WHODAS 2.0)
Oct 11, 2020 · WHODAS 2.0 is: A generic assessment instrument for health and disability A tool to produce standardized disability levels and profiles Applicable across cultures, in all adult populations …
Illness presentation and quality of life in [ME/CFS and LC]: a pilot ...
Jul 4, 2024 · The ME/CFS and PCC participants’ SF-36v2 or WHODAS 2.0 scores were comparable (all p > 0.05); however, both cohorts returned significantly lower scores in all SF-36v2 and WHODAS 2.0 …
Evaluation of a multidisciplinary neurological rehabilitation program ...
Feb 23, 2026 · No significant improvements could be shown fo r HRQoL, WHODAS-12, and all performance measures (MoCA, handgrip strength, walking, and balance) during the intervention …
Comparison of measures of functional capacity and the way the …
Jun 5, 2024 · WHODAS 2.0 covers 6 Domains of Functioning, including: Cognition – understanding & communicating Mobility– moving & getting around Self-care– hygiene, dressing, eating & staying …
disability assessment - Science for ME
Thread by: Midnattsol, Aug 28, 2023, 3 replies, in forum: Other health news and research Thread WHO Disability Assessment Schedule 2.0 (WHODAS 2.0) WHODAS 2.0 is: A generic assessment …
Evidence of White Matter Neuroinflammation in [ME/CFS]: A Diffusion ...
Mar 16, 2026 · To avoid group-size imbalance and maintain a 1:1 ratio of patients to HCs, nine ME/CFS participants (five PI-ME/CFS and four GO-ME/CFS participants, respectively) from the pooled cohort …
Novel characterization of endogenous transient receptor potential ...
Jun 26, 2024 · Novel characterization of endogenous transient receptor potential melastatin 3 ion channels from Gulf War Illness participants 2024 Marshall-Gradisnik
Self-reported symptom severity, general health, and impairment in …
Nov 27, 2022 · Both WHODAS 2.0 score and self-rated health were worst in subacute participants, and modestly worse in postcovid participants than in negative controls. Female gender, older age and …
Randomised feasibility study evaluating eye movement desensitisation ...
Jul 12, 2025 · Abstract Background Functional neurological disorder (FND) is a common neurological presentation with symptoms such as seizures, walking difficulties, limb weakness and cognitive …
Review - Molecular hydrogen as a treatment for ME/CFS: a mini-review …
Molecular hydrogen as a treatment for ME/CFS: a mini-review of clinical evidence and mechanistic rationale Friedberg, Fred; LeBaron, Tyler W. Abstract Myalgic encephalomyelitis/chronic fatigue …